GlaxoSmithKline defends itself against activist Elliott, recognizing need for ‘improved and sustained value’
July 02, 2021 at 06:34 AM EDT
Pharma giant responds to attack from U.S. activist fund Elliott, backing CEO Emma Walmsley.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|